BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 25341682)

  • 1. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Yehoshua L; Weiss I; Fox BD; Fruchter O; Kramer MR
    Respiration; 2014; 88(5):378-88. PubMed ID: 25341682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Soreck Y; Fruchter O; Kramer MR
    Lung; 2015 Jun; 193(3):345-54. PubMed ID: 25731736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised exercise training improves exercise cardiovascular function in idiopathic pulmonary fibrosis.
    Vainshelboim B; Kramer MR; Fox BD; Izhakian S; Sagie A; Oliveira J
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):209-218. PubMed ID: 27996217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program.
    Gaunaurd IA; Gómez-Marín OW; Ramos CF; Sol CM; Cohen MI; Cahalin LP; Cardenas DD; Jackson RM
    Respir Care; 2014 Dec; 59(12):1872-9. PubMed ID: 25185149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
    Kozu R; Senjyu H; Jenkins SC; Mukae H; Sakamoto N; Kohno S
    Respiration; 2011; 81(3):196-205. PubMed ID: 20516666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis].
    Vainshelboim B; Kramer MR
    Harefuah; 2012 Apr; 151(4):220-4, 253. PubMed ID: 22616150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis.
    Rammaert B; Leroy S; Cavestri B; Wallaert B; Grosbois JM
    Rev Mal Respir; 2011 Sep; 28(7):e52-7. PubMed ID: 21943547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council dyspnea grade.
    Kozu R; Jenkins S; Senjyu H
    Arch Phys Med Rehabil; 2014 May; 95(5):950-5. PubMed ID: 24502840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
    Kozu R; Jenkins S; Senjyu H
    Respirology; 2011 Nov; 16(8):1196-202. PubMed ID: 21810145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study.
    Strookappe B; Elfferich M; Swigris J; Verschoof A; Veschakelen J; Knevel T; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):43-52. PubMed ID: 26237355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Oxygen Delivery to Preserve Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis Treated with Nintedanib. Methodology of the HOPE-IPF Study.
    Ryerson CJ; Camp PG; Eves ND; Schaeffer M; Syed N; Dhillon S; Jensen D; Maltais F; O'Donnell DE; Raghavan N; Roman M; Stickland MK; Assayag D; Bourbeau J; Dion G; Fell CD; Hambly N; Johannson KA; Kalluri M; Khalil N; Kolb M; Manganas H; Morán-Mendoza O; Provencher S; Ramesh W; Rolf JD; Wilcox PG; Guenette JA
    Ann Am Thorac Soc; 2016 Sep; 13(9):1640-7. PubMed ID: 27348402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis.
    Arizono S; Taniguchi H; Sakamoto K; Kondoh Y; Kimura T; Kataoka K; Ogawa T; Watanabe F; Nishiyama O; Nishimura K; Kozu R; Tabira K
    Respir Care; 2014 Jul; 59(7):1108-15. PubMed ID: 24327743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Improvement in Physical Activity and Body Composition After Supervised Exercise Training Program in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Fox BD; Kramer MR; Izhakian S; Gershman E; Oliveira J
    Arch Phys Med Rehabil; 2016 May; 97(5):788-97. PubMed ID: 26869288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis--a review.
    Kenn K; Gloeckl R; Behr J
    Respiration; 2013; 86(2):89-99. PubMed ID: 23942353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease.
    Holland AE; Hill CJ; Glaspole I; Goh N; McDonald CF
    Respir Med; 2012 Mar; 106(3):429-35. PubMed ID: 22182340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise training in idiopathic pulmonary fibrosis.
    Vainshelboim B; Fox BD; Oliveira J; Kramer MR
    Expert Rev Respir Med; 2016; 10(1):69-77. PubMed ID: 26567878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease.
    Holland AE; Hill CJ; Conron M; Munro P; McDonald CF
    Thorax; 2008 Jun; 63(6):549-54. PubMed ID: 18245143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
    du Bois RM; Weycker D; Albera C; Bradford WZ; Costabel U; Kartashov A; Lancaster L; Noble PW; Sahn SA; Szwarcberg J; Thomeer M; Valeyre D; King TE
    Am J Respir Crit Care Med; 2011 May; 183(9):1231-7. PubMed ID: 21131468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
    Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
    Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.